Interacting Drugs |
Methylprednisolone vs CYP3A4 Inhibitors (Strong) |
Security Level |
|
Mechanism |
CYP3A4 Inhibitors (Strong): May increase the serum concentration of MethylPREDNISolone. |
Management |
Consider methylprednisolone dose titration and/or adjustments in patients receiving strong CYP3A4 inhibitors (eg, azole antifungals, protease inhibitors) and monitor for increased steroid related adverse effects. |
Methylprednisolone vs CYP3A4 Inhibitors (Strong)
Post Review about Methylprednisolone vs CYP3A4 Inhibitors (Strong) Click here to cancel reply.
Other Interactions of Methylprednisolone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.